Vivos (RDGL) Change in Accured Expenses (2010 - 2025)
Vivos' (RDGL) quarterly Change in Accured Expenses came in at -$20221.0 in Q4 2025, down 154.08% year-on-year from $37389.0 in Q4 2024, and down 224.55% quarter-over-quarter from $16235.0 in Q3 2025.
Vivos (RDGL) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Vivos has disclosed Change in Accured Expenses across 16 years of filings, most recently posting -$20221.0 for Q4 2025.
- Change in Accured Expenses for Q4 2025 came in at -$20221.0, down 154.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $6263.0 (up 103.94% YoY), and the FY2025 annual result was $6263.0, up 103.94% from the prior year.
- Change in Accured Expenses came in at -$20221.0 for Q4 2025 at Vivos, down from $16235.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $176085.0 in Q4 2023 to a low of -$170238.0 in Q1 2024.
- The 5-year median for Change in Accured Expenses is -$17146.5 (2021), against an average of $1271.9.
- Across the five-year window, Change in Accured Expenses soared 7895.04% in 2021 and tumbled 662.52% in 2024, its largest moves.
- Vivos' Change in Accured Expenses stood at -$55916.0 in 2021, then sank by 41.75% to -$79261.0 in 2022, then surged by 322.16% to $176085.0 in 2023, then slumped by 78.77% to $37389.0 in 2024, then tumbled by 154.08% to -$20221.0 in 2025.
- The last three Change in Accured Expenses figures came in at -$20221.0 (Q4 2025), $16235.0 (Q3 2025), and -$18920.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Vivos | - | - | -3,105.00 | -20,221.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20,221.00 |
| Dec 31, 2025 | -20,221.00 |
| Sep 30, 2025 | 16,235.00 |
| Sep 30, 2025 | 16,235.00 |
| Jun 30, 2025 | -18,920.00 |
| Jun 30, 2025 | -18,920.00 |
| Mar 31, 2025 | 29,169.00 |
| Mar 31, 2025 | 29,169.00 |
| Dec 31, 2024 | 37,389.00 |
| Dec 31, 2024 | 37,389.00 |
| Sep 30, 2024 | -117,740.00 |
| Sep 30, 2024 | -117,740.00 |
| Jun 30, 2024 | 91,794.00 |
| Jun 30, 2024 | 91,794.00 |
| Mar 31, 2024 | -170,238.00 |
| Mar 31, 2024 | -170,238.00 |
| Dec 31, 2023 | 176,085.00 |
| Dec 31, 2023 | 176,085.00 |
| Sep 30, 2023 | -15,441.00 |
| Sep 30, 2023 | -15,441.00 |